The authors note that semaglutide had a holistic therapeutic approach to both liver disease and associated cardiometabolic illnesses. These results lend further credence that semaglutide is the Swiss army knife of medicine we have been looking for, to treat obesity, cardiovascular disease, type 2 diabetes, and now MASH, Beverly Tchang, MD, an endocrinologist and assistant professor of clinical medicine at Weill Cornell Medicine, not affiliated with the trial, told Healthline.
The correct angle depends on your body composition and needle length
Early reports show that many patients using the medication experienced noticeable improvement, sparking new research into its potential to restore energy and reduce inflammation linked to the condition.
Pivotal clinical trials in continuous ketone monitoring, akin to currently available continuous glucose monitoring, are taking place in 2023 [53]
Semaglutide for the Treatment of Type 2 Diabetes Mellitus
doi: 10.1016/j.bbamcr.2016.01.023